Delegates at 2004

There were a total of total of 211 participants at the conference over the three days. Of these 75% were senior management and above. Participants came from 15 different countries but the US dominated.

Companies represented were:

3M Company - 3M Pharmaceuticals
3M Drug Delivery Systems
Acambis Inc.
Aeras Global TB Vaccine Foundation
Agencourt Bioscience
Althea Technologies
Andino Lab
Apovia AG
Arent Fox
Avant Immunotherapeutics
Avecia Biotechnology
Aventis Pasteur
Battelle
Bavarian Nordic GmbHH
Baxter Bioscience
Baxter Pharma. Solutions
Baxter Pharmaceutical Solutions LLC
Baxter Vaccines
BD
BD Immunization
Beckman Coulter, Inc.
Bioject Medical Technologies
BioReliance Corporation
BioSante Pharmaceuticals
BioVex Ltd
Biovirx, Inc.
Birmex
Brock University
Brown University
Cambrex Biopharmaceutical Manufacturing Services
Canadian Network for Vaccines and Immunotherapeutics
CanVac
Cardinal Health
CBC Television
Centro Hospitalar Vila Nova de Gaia
Chiron Corporation
Chiron Vaccines
CIM
CIMAB
Clinimetrics Research Canada
CNRS BioMerieuz FRE
Cobra Biomanufacturing
Coley Pharmaceutical Group
Crucell
DARPA/DSO
Delsite Biotechnologies Inc
Dendreon
Department National Defence
Department of Health
Dept. of National Defence
Diosynth RTP, Inc
DSTL
DynPort Vaccine Company LLC
Endpoint Research
Entremed, Inc
Epimmune Inc.
EpiVax
Esteve Farma, LDA
FDA
Focus Technologies, Inc.
GenVec, Inc
Geovax Inc
GlaxoSmithKline
Globe & Mail
GSK Biologicals
Health Canada
Henry Schein
Henryj Schein, Inc.
Hospiatl S. Marcos
Hospital de Cascais
HPA Porton Down
IAVI
ICI Pakistan Ltd
ID Biomedical Corporation
IDT GmbH
Immuno-Designed Molecules (IDM)
Imperial College
Institute of Immunology Inc.
Invitrogen Ltd
Iomai Corporation
J&J Pharm Reg & Dev
Johns Hopkins Bloomberg School of Public Health
Johnson & Johnson
Kryotrans
Laboratorio Pablo Cassara
Large Scale Biology Corporation
Lark Technologies Inc
Malaria Vaccine Initiative
Marshall,Gerstein & Borun
Maxygen, Inc.
McMaster University
Medarex
Medicago inc.
Mercer University
Merck & Co, Inc.
Merck Research Laboratories
Merix Bioscience
Microscience
Microscience Ltd
Ministhre du diveloppement iconomique et rigional
Molecular Medicine BioServices
Nabi Biopharmaceuticals
National Institue of Healtth
Neovacs S A
NIAID
Nunc A/S
Ontaria MEDT
Oxford Bioscience Partners
Private Practice
ProBioGen AG
Quebec Science
Quester Capital Management Ltd
Quintiles
Radio Canada
Sabin Vaccine Institute
SARS Accelerated Vaccine Initiative
Saskatchewan Research Council
Schreiner GmbH & Co. KG
Schreiner Medi Pharm-Nuova Ompi
SeqWright, Inc
Shire Biologics
Solvay Pharmaceuticals
Spherics
State Research Center Virology and Biotechnology VECTOR
Stedim Inc
Stressgen Biotechnologies
The Medical Post
Toronto General Research Institute
Transgene
University of Montreal
USP Pharmacopia
VACSERA
VaxGen
Vical
VIDO
Wyeth-Ayerst Research